HEMNOS

Clinical trials for HEMNOS explained in plain language.

Never miss a new study

Get alerted when new HEMNOS trials appear

Sign up with your email to follow new studies for HEMNOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take aim at childhood liver cancers

Disease control Recruiting now

This trial investigates a new cell therapy called ET140203 T cells for children and young adults (ages 1–21) with certain liver cancers—hepatoblastoma, hepatocellular carcinoma, or related tumors—that have come back or not responded to standard treatment. Participants must have h…

Matched conditions: HEMNOS

Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

HEMNOS

Get alerted when new HEMNOS trials appear

Engineered immune cells take aim at childhood liver cancers